Talaris Therapeutics

Talaris Therapeutics is a therapeutic based company.

Launch date

2002

Employees

Market cap

Enterprise valuation

(€22m) (Public information from Oct 2023)

Louisville Kentucky (HQ)

Revenues, earnings & profits over time

Date	Investors	Amount	Round
Apr 2019	Blackstone Longitude Capital Qiming Venture Partners USA	$100m	Series A
Apr 2019*	Blackstone	$100m	Series A
Oct 2020	Blackstone BlackRock Invus Aisling Capital Citadel Viking Global Investors Longitude Capital Cormorant Asset Management Eventide Asset Management Pamoja Capital Group Logos Capital Qiming Venture Partners USA	$115m	Series B
May 2021	N/A	N/A	IPO
Jun 2023*	Tourmaline Bio	N/A	Acquisition
Total Funding		€286m

Tech stackLearn more about the technologies and tools that this company uses.

Financials